The LBFGS quasi-Newtonian method for molecular modeling prion AGAAAAGA amyloid fibrils

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Natural Science

ISSN Print: 2150-4091
ISSN Online: 2150-4105
www.scirp.org/journal/ns
E-mail: ns@scirp.org

Google-based Impact Factor: 0.74
Citations h5-index & Ranking

Journals Menu

"The LBFGS quasi-Newtonian method for molecular modeling prion AGAAAAGA amyloid fibrils"
written by Jiapu Zhang, Yating Hou, Yiju Wang, Changyu Wang, Xiangsun Zhang,
published by Natural Science, Vol.4 No.12A, 2012

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB
	Jackson… - Life Sciences, 2022

[2]	To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations
	Journal of …, 2022

[3]	AN IN SILICO STUDY OF THE DELTA OPIOID RECEPTOR USING SMALL MOLECULES
	2022

[4]	Elucidation of Partial Activation of Cannabinoid Receptor Type 2 and Identification of Potential Partial Agonist: Molecular Dynamics Simulation and Structure …
	2022

[5]	Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations
	2021

[6]	Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation
	2021

[7]	To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor …
	2021

[8]	Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study
	2020

[9]	Binding of agonist WAY-267,464 and antagonist WAY-methylated to oxytocin receptor probed by all-atom molecular dynamics simulations
	2020

[10]	Risk Assessment of Closed-Loop Supply Chain for Electronic Products Recycling and Reuse Based on Fuzzy BP Neural Network
	2020

[11]	Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic …
	2020

[12]	Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy
	2019

[13]	Molecular insights into the interaction of hemorphin and its targets
	2019

[14]	To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit …
	Physical Chemistry Chemical Physics, 2018

[15]	Investigating detailed interactions between novel PAR1 antagonist F16357 and the receptor using docking and molecular dynamic simulations
	Journal of Molecular Graphics and Modelling, 2017

[16]	Can human allergy drug fexofenadine, an antagonist of histamine (H1) receptor, be used to treat dog and cat? Homology modeling, docking and molecular dynamic Simulation …
	Journal of Molecular Graphics and Modelling, 2017

[17]	Mathematical Formulas for Prion All Cross-β Structures Listed in the Protein Data Bank
	2016

[18]	Structural and dynamic analysis of wild and splice variants human μ-opioid receptors in complex with morphine and IBNtxA and human topoisomerase II …
	ProQuest Dissertations Publishing, 2016

[19]	The Hybrid Idea of Optimization Methods Applied to the Energy Minimization of (Prion) Protein Structures
	arXiv preprint arXiv:1504.03614, 2015

[20]	An Optimization Model of Molecular Voronoi Cells in Computational Chemistry
	Biochemistry & Pharmacology: Open Access, 2015

[21]	Molecular structures and structural dynamics of prion proteins and prions
	Focus on Structural Biology book series, 2015

[22]	The Hybrid Idea of (Energy Minimization) Optimization Methods Applied to Study Prion Protein Structures Focusing on the beta2-alpha2 Loop
	Biochem Pharmacol (Los Angel), 2015

[23]	Biochemistry & Pharmacology: Open Access
	2015

[24]	Molecular Structures and Structural Dynamics of Prion Proteins and Prions: Mechanism Underlying the Resistance to Prion Diseases
	2015

[25]	The Sensor Network in Molecular Structures of PrP (113-120) AGAAAAGA Amyloid Fibrils
	J Comput Sci Syst Biol, 2014

[26]	Molecular dynamics studies on 3D structures of the hydrophobic region PrP (109-136)
	Acta biochimica et biophysica Sinica, 2013

[1]	To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations Journal of Biomolecular Structure and Dynamics, 2023 DOI:10.1080/07391102.2022.2107074

[2]	To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations Journal of Biomolecular Structure and Dynamics, 2022 DOI:10.1080/07391102.2022.2107074

[3]	To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations ACS Chemical Neuroscience, 2021 DOI:10.1021/acschemneuro.1c00135

[4]	Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations ACS Chemical Neuroscience, 2021 DOI:10.1021/acschemneuro.1c00126

[5]	To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations ACS Chemical Neuroscience, 2021 DOI:10.1021/acschemneuro.1c00135

[6]	Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations ACS Chemical Neuroscience, 2021 DOI:10.1021/acschemneuro.1c00126

[7]	LISS2019 2020 DOI:10.1007/978-981-15-5682-1_11

[8]	Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis Journal of Chemical Information and Modeling, 2020 DOI:10.1021/acs.jcim.9b01082

[9]	Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis Journal of Chemical Information and Modeling, 2020 DOI:10.1021/acs.jcim.9b01082

[10]	Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy Journal of Medicinal Chemistry, 2019 DOI:10.1021/acs.jmedchem.9b00231

[11]	Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy Journal of Medicinal Chemistry, 2019 DOI:10.1021/acs.jmedchem.9b00231

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Natural Science

Natural Science

Journals Menu

Home

About SCIRP

Service

Policies